Drugs / CDH17 CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06937567 | Dec 2024 → Mar 2028 expected | biliary tract cancer, colorectal carcinoma, gastric cancer, pancreatic ductal adenocarcinoma | Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDH17 CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06937567 ↗ |